Serum 25(OH)D levels after oral vitamin D3 supplementation and UVB exposure correlate

Photodermatol Photoimmunol Photomed. 2019 Sep;35(5):344-353. doi: 10.1111/phpp.12491. Epub 2019 Jul 21.

Abstract

Background: The inter-individual variation in 25(OH)D3 increase (Δ25(OH)D3 ) after vitamin D3 supplementation was determined and compared with the UVB irradiation response.

Methods: Nineteen Danish participants received 85 μg vitamin D3 (cholecalciferol) daily for nine weeks with regular serum 25(OH)D3 measurements. These participants had three years earlier taken part in a 9-week controlled UVB study. The Δ25(OH)D3 was not confounded by ambient UVB, BMI or ethnicity.

Results: Δ25(OH)D3 was 53 nmol L-1 and almost identical to Δ25(OH)D3 (52 nmol L-1 ) after UVB. Δ25(OH)D3 ranged from 17 to 91 nmol L-1 (span 74 nmol L-1 ) and was about half of that observed after UVB irradiation (span 136 nmol L-1 ). The interquartile ranges for vitamin D3 supplementation (38.8-71.4 nmol L-1 , span: 32.6 nmol L-1 ) and UVB irradiation (35.7-65.4 nmol L-1 , span: 29.7 nmol L-1 ) were similar indicating a comparable response of the two interventions. As the 25(OH)D3 start levels (R2 = 0.398, P = 3.8 × 10-3 ), 25(OH)D3 end levels (R2 = 0.457, P = 1.5 × 10-3 ) and Δ25(OH)D3 (R2 = 0.253, P = 0.028) between both interventions were correlated, this suggested a possible common individual background for the variation. Four pigment SNPs influenced the variation in the vitamin D3 -induced and UVB-induced Δ25(OH)D3 . A combined model including the influence of these four SNPs and the 25(OH)D3 start level explained 86.8% (P = 1.6 × 10-35 ) of the individual variation after vitamin D3 supplementation.

Conclusion: The inter-individual variation in the two interventions was comparable and had no common demographic but a partly common genetic background.

Keywords: 25(OH)D; UVB; inter-individual variation; pigment genes; vitamin D3 supplementation.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Calcifediol / blood*
  • Cholecalciferol / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Seasons*
  • Ultraviolet Rays / adverse effects*

Substances

  • Cholecalciferol
  • Calcifediol